GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tsumura & Co (OTCPK:TSMRF) » Definitions » COGS-to-Revenue

Tsumura (Tsumura) COGS-to-Revenue : 0.61 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Tsumura COGS-to-Revenue?

Tsumura's Cost of Goods Sold for the three months ended in Mar. 2024 was $142 Mil. Its Revenue for the three months ended in Mar. 2024 was $234 Mil.

Tsumura's COGS to Revenue for the three months ended in Mar. 2024 was 0.61.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Tsumura's Gross Margin % for the three months ended in Mar. 2024 was 39.28%.


Tsumura COGS-to-Revenue Historical Data

The historical data trend for Tsumura's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tsumura COGS-to-Revenue Chart

Tsumura Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 0.48 0.49 0.51 0.54

Tsumura Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 0.55 0.54 0.49 0.61

Tsumura COGS-to-Revenue Calculation

Tsumura's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=547.522 / 1006.851
=0.54

Tsumura's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=141.919 / 233.743
=0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tsumura  (OTCPK:TSMRF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Tsumura's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 141.919 / 233.743
=39.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Tsumura COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Tsumura's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Tsumura (Tsumura) Business Description

Traded in Other Exchanges
Address
2-17-11, Akasaka, Minato-ku, Tokyo, JPN, 107-8521
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Tsumura (Tsumura) Headlines

From GuruFocus

Q2 2020 Tsumura & Co Earnings Presentation Transcript

By GuruFocus Research 02-15-2024